文献速递细菌感染、耐药与抗菌药物医院感染防控

芬兰2004-2018年血流感染发病率与死亡率的基于人群研究

Population-Based Study of Bloodstream Infection Incidence and Mortality Rates, Finland, 2004-2018.
PubMed 文献 · Emerg Infect Dis · 2021-01-01

该研究利用芬兰国家登记数据评估2004-2018年血流感染(BSI)的发病率、结局和病原体。共识别173,715例BSI,年发病率从150例/10万人口升至309例/10万人口,1个月全因死亡率从20例/10万人口升至39例/10万人口。大肠埃希菌所致BSI占比从26%升至30%,多重耐药菌所致BSI从0.4%升至2.8%,社区获得性BSI从67%升至78%。

要点

  • 芬兰BSI年发病率从150升至309例/10万人口,>80岁人群上升最明显。
  • 1个月病死率从13.0%降至12.6%,但全因死亡率从20升至39例/10万人口。
  • 多重耐药菌所致BSI从0.4%升至2.8%,主要为产超广谱β-内酰胺酶大肠埃希菌。

核心结论

  • 芬兰2004-2018年BSI发病率翻倍,全因死亡率也翻倍,需加强公共卫生和医疗预防措施。
  • 社区获得性BSI和耐药大肠埃希菌所致BSI增加,是防控重点。

研究设计与样本

  • 基于芬兰国家登记数据的基于人群研究,纳入2004-2018年共173,715例BSI。

主要发现

  • BSI年发病率从150例/10万人口升至309例/10万人口,>80岁人群上升最急剧。
  • 1个月病死率从13.0%降至12.6%,但1个月全因死亡率从20例/10万人口升至39例/10万人口。
  • 大肠埃希菌所致BSI占比从26%升至30%,多重耐药菌所致BSI从0.4%升至2.8%,主要为产ESBL大肠埃希菌。
  • 社区获得性BSI占比从67%升至78%,有严重基础疾病患者比例从14%升至23%。

临床怎么用

  • 临床应关注社区获得性BSI增加趋势,尤其老年人群。
  • 经验性抗菌治疗需考虑产ESBL大肠埃希菌等耐药菌风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We evaluated the incidence, outcomes, and causative agents of bloodstream infections (BSI) in Finland during 2004–2018 by using data from the national registries. We identified a total of 173,715 BSIs; annual incidence increased from 150 to 309 cases/100,000 population. BSI incidence rose most sharply among persons >80 years of age. The 1-month case-fatality rate decreased from 13.0% to 12.6%, but the 1-month all-cause mortality rate rose from 20 to 39 deaths/100,000 population. BSIs caused by Escherichia coli increased from 26% to 30% of all BSIs. BSIs caused by multidrug-resistant microbes rose from 0.4% to 2.8%, mostly caused by extended-spectrum β-lactamase-producing E. coli. We observed an increase in community-acquired BSIs, from 67% to 78%. The proportion of patients with severe underlying conditions rose from 14% to 23%. Additional public health and healthcare prevention efforts are needed to curb the increasing trend in community-acquired BSIs and antimicrobial drug–resistant E. coli. A 2-fold increase in incidence and death during this period emphasizes the need for additional prevention efforts.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kontula KSK, Skogberg K, Ollgren J, et al. Population-Based Study of Bloodstream Infection Incidence and Mortality Rates, Finland, 2004-2018. Emerg Infect Dis. 2021. PMID: 34546161. doi:10.3201/eid2710.204826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。